Vian Analytics Pushes Artificial Intelligence Drug Discovery Toward Transparency
Share this Post

Vian Analytics Pushes Artificial Intelligence Drug Discovery Toward Transparency


Vian’s minimum viable product focuses on repurposing, where existing compounds are screened for new use in oncology projects. Under the hood sits a graph-based architecture that weaves together multiple data types.  Genetic variants, expression signals, …

Other Blogs

From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains Business Transformation

Nov 25, 2025

From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains
Readmore
From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains Business Transformation

Nov 25, 2025

From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains
Readmore
From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains Business Transformation

Nov 25, 2025

From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains
Readmore
From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains Business Transformation

Nov 25, 2025

From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains
Readmore
From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains Business Transformation

Nov 25, 2025

From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains
Readmore